Trademark: 97826069
Word
ONCYFA
Status
Registered
Status Code
700
Status Date
Tuesday, December 19, 2023
Serial Number
97826069
Registration Number
7249313
Registration Date
Tuesday, December 19, 2023
Mark Type
4000
Filing Date
Tuesday, March 7, 2023
Published for Opposition
Tuesday, October 3, 2023

Trademark Owner History
Fresenius Kabi Deutschland GmbH - Original Registrant

Classifications
5 Pharmaceutical preparations for human use for the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for the prevention of fractures; pharmaceutical preparations for human use for prevention of pain associated with oncological and metabolic diseases and disorders; pharmaceutical preparations for human use for surgery, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for radiotherapy, namely, for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors; pharmaceutical preparations for human use for the treatment and prevention of bone metastases, solid tumors, osteolytic bone lesions of multiple myeloma, hypercalcemia of malignancy, giant cell tumor of bone

Trademark Events
Dec 19, 2023
Notice Of Registration Confirmation Emailed
Dec 19, 2023
Registered-Principal Register
Oct 3, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 3, 2023
Published For Opposition
Sep 13, 2023
Notification Of Notice Of Publication E-Mailed
Aug 24, 2023
Approved For Pub - Principal Register
Mar 21, 2023
Preliminary/Voluntary Amendment - Entered
Aug 21, 2023
Assigned To Examiner
Jun 8, 2023
Teas Voluntary Amendment Received
Mar 27, 2023
New Application Office Supplied Data Entered
Mar 10, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24